SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001005286-24-000071
Filing Date
2024-05-22
Accepted
2024-05-22 16:30:08
Documents
17
Period of Report
2024-05-19
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lndc-20240519.htm   iXBRL 8-K 41082
2 EX-10.1 exhibit101lifecorersuaward.htm EX-10.1 29426
3 EX-10.2 exhibit102lifecorepsuaward.htm EX-10.2 50223
4 EX-10.3 exhibit103lifecoreparticip.htm EX-10.3 10678
8 image_0.jpg GRAPHIC 56620
  Complete submission text file 0001005286-24-000071.txt   358093

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20240519.xsd EX-101.SCH 1983
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20240519_lab.xml EX-101.LAB 21885
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20240519_pre.xml EX-101.PRE 12591
20 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20240519_htm.xml XML 2690
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: 8-K | Act: 34 | File No.: 000-27446 | Film No.: 24973721
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)